Literature DB >> 32238463

GATA1 gets personal.

Anna Rita Migliaccio1.   

Abstract

Entities:  

Year:  2020        PMID： 32238463      PMCID： PMC7109728          DOI： 10.3324/haematol.2019.246355

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  13 in total

1.  Personalized medicine: part 1: evolution and development into theranostics.

Authors:  F Randy Vogenberg; Carol Isaacson Barash; Michael Pursel
Journal:  P T       Date:  2010-10

2.  Personalized medicine: part 2: ethical, legal, and regulatory issues.

Authors:  F Randy Vogenberg; Carol Isaacson Barash; Michael Pursel
Journal:  P T       Date:  2010-11

3.  Personalized medicine: part 3: challenges facing health care plans in implementing coverage policies for pharmacogenomic and genetic testing.

Authors:  F Randy Vogenberg; Carol Isaacson Barash; Michael Pursel
Journal:  P T       Date:  2010-12

Review 4.  GATA1 insufficiencies in primary myelofibrosis and other hematopoietic disorders: consequences for therapy.

Authors:  Te Ling; John D Crispino; Maria Zingariello; Fabrizio Martelli; Anna Rita Migliaccio
Journal:  Expert Rev Hematol       Date:  2018-02-19       Impact factor: 2.929

Review 5.  The hazards of blood transfusion in historical perspective.

Authors:  Harvey J Alter; Harvey G Klein
Journal:  Blood       Date:  2008-10-01       Impact factor: 22.113

6.  Genome-wide association study of hematological and biochemical traits in a Japanese population.

Authors:  Yoichiro Kamatani; Koichi Matsuda; Yukinori Okada; Michiaki Kubo; Naoya Hosono; Yataro Daigo; Yusuke Nakamura; Naoyuki Kamatani
Journal:  Nat Genet       Date:  2010-02-07       Impact factor: 38.330

7.  Realizing the Full Potential of Precision Medicine in Health and Health Care.

Authors:  Victor J Dzau; Geoffrey S Ginsburg
Journal:  JAMA       Date:  2016-10-25       Impact factor: 56.272

8.  Fv2 encodes a truncated form of the Stk receptor tyrosine kinase.

Authors:  D A Persons; R F Paulson; M R Loyd; M T Herley; S M Bodner; A Bernstein; P H Correll; P A Ney
Journal:  Nat Genet       Date:  1999-10       Impact factor: 38.330

9.  The aging population poses a global challenge for blood services.

Authors:  Akif Ali; Marja-Kaisa Auvinen; Jukka Rautonen
Journal:  Transfusion       Date:  2009-11-13       Impact factor: 3.157

10.  Aurora Kinase A Inhibition Provides Clinical Benefit, Normalizes Megakaryocytes, and Reduces Bone Marrow Fibrosis in Patients with Myelofibrosis: A Phase I Trial.

Authors:  Naseema Gangat; Christian Marinaccio; Ronan Swords; Justin M Watts; Sandeep Gurbuxani; Alfred Rademaker; Angela J Fought; Olga Frankfurt; Jessica K Altman; Qiang Jeremy Wen; Noushin Farnoud; Christopher A Famulare; Akshar Patel; Roberto Tapia; Rangit R Vallapureddy; Stephanie Barath; Amy Graf; Amy Handlogten; Darci Zblewski; Mrinal M Patnaik; Aref Al-Kali; Yvonne Trang Dinh; Kristen Englund Prahl; Shradha Patel; Juan Carlos Nobrega; Dalissa Tejera; Amber Thomassen; Juehua Gao; Peng Ji; Raajit K Rampal; Francis J Giles; Ayalew Tefferi; Brady Stein; John D Crispino
Journal:  Clin Cancer Res       Date:  2019-05-06       Impact factor: 12.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.